Immunogenicity of killed Bordetella bronchiseptica vaccines in the mouse.
Two intramuscular injections (two weeks apart of graded doses of killed strains of Bordetella bronchiseptica from the pig (OLN 14 or LBF 1) or the dog (D1) had produced in mice circulating agglutinins ranging in mean titre (log2) per group from about 3.3 to 10.2 two weeks later. These levels depended partly on vaccinal strains and dose, and partly on the strain used as agglutinogen. Other such mice were challenged intraperitoneally with about 50 LD50 (approximately or equal to 10(7.4) viable bacteria) of two pig strains, one (293) from a British case of atrophic rhinitis and the other (N) from an American herd. Against challenge vaccinal strain OLN 14 was about 10 and LBF 1 about 100 times more immunogenic than vaccinal strain D1. In a separate experiment mice given intramuscularly amounts of LBF 1 or D1 vaccine estimated as being immunogenically equivalent were challenged intraperitoneally with one or other of seven pig or seven dog strains. On aggregate each vaccine protected to about the same extent against challenge by the pig strains, although LBF 1 vaccine was less effective than D1 vaccine against a strain of Danish origin. Both vaccines also protected more mice against challenge by the dog than the pig strans but LBF 1 vaccine was somewhat less effective than D1 vaccine, especially when challenged by strain D1.
D000818:Animals; D000907:Antibodies, Bacterial / Q000032:analysis; D000917:Antibody Formation; D001428:Bacterial Vaccines / Q000008:administration & dosage / Q000276:immunology*; D001884:Bordetella / Q000276:immunology* / Q000302:isolation & purification; D001885:Bordetella Infections / Q000517:prevention & control / Q000662:veterinary; D004285:Dogs / Q000382:microbiology; D007273:Injections, Intramuscular; D051379:Mice / Q000276:immunology*; D012376:Rodent Diseases / Q000517:prevention & control; D013552:Swine / Q000382:microbiology
D000907:Antibodies, Bacterial; D001428:Bacterial Vaccines